Wird geladen...
Efficacy and Safety of Saxagliptin as Add-On Therapy in Type 2 Diabetes
Combination therapy for type 2 diabetes using agents with complementary mechanisms of action may improve glycemic control to a greater extent than monotherapy and allow the use of lower doses of antihyperglycemic medications. Dipeptidyl peptidase-4 inhibitors, including saxagliptin, are recommended...
Gespeichert in:
| Veröffentlicht in: | Clin Diabetes |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Diabetes Association
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4220591/ https://ncbi.nlm.nih.gov/pubmed/25646943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/diaclin.32.4.170 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|